血府逐瘀胶囊治疗血瘀型肺心病的临床疗效

Clinical Effect of Xuefu Zhuyu Capsule (XZC)on Pulmonary Heart Disease with Blood Stasis

关键词:  血府逐瘀胶囊  肺心病  血瘀型  疗效观察

Key words:  Xuefu Zhuyu Capsule  pulmonary heart disease  blood stasis type  clinical observation

摘要:

目的:观察血府逐瘀胶囊对血瘀型肺心病的治疗效果。方法:40例血瘀型肺心病患者随机分为两组,在常规治疗同时,治疗组使用血府逐瘀胶囊,对照组使用肠溶阿斯匹林,28～30d为1个疗程,将治疗前后症状、体征及血常规、血流变检查进行记录。结果:治疗组总有效率为95%,对照组总有效率为70%,两组比较有显着性差异,P<0.05.两组血流变、血小板、纤维蛋白原均有改善,两组比较有显着性差异,P<0.05。结论:血府逐瘀胶囊为治疗血瘀型肺心病提供了有效的方法,且安全、有效、不良反应少。

Abstract:

Objective: To observe the therapeutic effect of XZC on pulmonary heart disease with blood stasis. Method: 40 cases were divided into 2 groups: the treatment group (given XZC) and the control group (given bowel-soluble aspirin) with 28 to 30 days a course. Symptoms, signs and indexes of blood routine test and rheology were recorded before and after treatment. Result: The total effects were 95% and 70% in treatment group and control group respectively, and there was an obvious difference between them (P<0.05). The indexes of blood rheology, blood platelet, fibrinogen in both groups were improved, but difference between them were obvious (P<0.05). Conclusion: XZC provides an effective and safe method to treat pulmonary heart disease of blood stasis type with fewer side effects.